
DocMorris operates an online pharmacy and telemedicine business whose assortment covers prescription medicines and personal care for customers.
corporate.docmorris.comCrawled Oct 26, 2026
The page highlights key events in DocMorris’s history as it works to become the first point of contact for digital health.
DocMorris is Germany’s largest online pharmacy.
DocMorris is Germany’s largest online pharmacy.
The Zur Rose Group’s privacy policy explains how it processes user data.
The Zur Rose Group’s privacy policy explains how it processes data.
The imprint provides details on ownership and authorship of DocMorris’s corporate website.
The imprint offers information on ownership and authorship of DocMorris’s corporate website.
The legal notice outlines the legal framework governing the company’s website.
The legal notice describes the legal framework for DocMorris’s corporate website.
DocMorris increases its 2026 revenue forecast following growth in its prescription (Rx) business segment. The company cites expanding demand for its pharmaceutical services as a key driver for the revised outlook.
Nov 2026TipRanksNews article
DocMorris increases its full-year revenue forecast following continued growth in its prescription (Rx) business. The update is part of the company’s Capital Markets Day, highlighting sustained performance in its core healthcare services. The adjustment reflects strong demand and operational expansion in its pharmaceutical retail segment.
Nov 2026TradingViewNews article
TeleClinic, a DocMorris subsidiary, acquires Medi24, Switzerland’s largest telemedicine provider, from Allianz Partners. The move integrates Medi24’s expertise to strengthen TeleClinic’s digital healthcare services in Germany’s emergency and primary care sectors. Medi24’s established experience aims to support TeleClinic’s expansion in key medical domains.
Nov 2026heise onlineNews article
TeleClinic, a subsidiary of DocMorris, acquires Medi24, a Swiss telemedicine provider, from Allianz Partners. The deal expands TeleClinic’s presence in Switzerland, reinforcing its leadership in telemedicine across Germany and Switzerland. The transaction targets consolidation in the digital healthcare market.
Nov 2026Investors in HealthcareNews article